Examining the direct and indirect effects of trust in motivating COVID-19 vaccine uptake.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35181177.
- Also identified by DOI 10.1016/j.pec.2022.02.009 and PMC identifier 8840822.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aims to investigate how trust in healthcare providers, public health agencies, politicians, and pharmaceutical companies shaped people's attitudes and behavioral intention associated with COVID-19 vaccination, directly and indirectly via the mediation of vaccine evaluation and emotions. A two-wave longitudinal survey (N = 534) was employed in late 2020 and early 2021 to assess the direct and indirect relationships between trust on people's attitude toward the COVID-19 vaccine, vaccination intention, and actual vaccine uptake. Results show that trust was positively associated with attitude toward the COVID-19 vaccines and vaccination intention, both directly and indirectly via the mediation of vaccine evaluation, hope, and anger. Vaccination intention also mediated trust's influence on vaccine uptake. Trust in health providers, vaccine manufacturers, and public health agencies are vital to public acceptance of the COVID-19 vaccine. Healthcare providers and vaccine manufacturers may serve as the most effective source to communicate COVID-19 vaccine-related information. Trusted health communicators need to highlight the effectiveness and safety of the vaccine while maintaining a positive tone.
Medical subject headings
- COVID-19
- Influenza Vaccines